Real-world data of durvalumab plus gemcitabine and cisplatin in patients with advanced biliary tract cancer: A Thailand multicenter observational study

被引：0

作者：

Tanasanvimon, Suebpong

Maneenil, Kunlatida

Wirasorn, Kosin

Thanasombunsukh, Kijjakom

Korphaisarn, Krittiya

Sathitruangsak, Chirawadee

Wanchaijiraboon, Passakorn

Siripoon, Teerada

Teeyapan, Nattaya

Charonpongsuntorn, Chanchai

Suksombooncharoen, Thatthan

Thambamroong, Tawasapon

Laosuangkoon, Wannisa

Ngokngarm, Chavapon

Simseekeaw, Pronwasun

Akewanlop, Charuwan

Sirachainan, Ekaphop

TSCO GI Grp

机构：

[1] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Dept Internal Med,Fac Med, Bangkok, Thailand

[2] Rajavithi Hosp, Bangkok, Thailand

[3] Khon Kaen Univ, Fac Med, Mueang Khon Kaen, Thailand

[4] Minist Publ Hlth, Lampang Hosp, Lampang, Thailand

[5] Siriraj Hosp, Bangkok Noi, Thailand

[6] Prince Songkla Univ, Hat Yai, Thailand

[7] Phrapokklao Hosp, Phrapokklao Canc Ctr Excellence, Chanthaburi, Thailand

[8] Mahidol Univ, Ramathibodi Hosp, Ratchathewi, Thailand

[9] King Chulalongkorn Mem Hosp, Bangkok, Thailand

[10] Srinakharinwirot Univ, Fac Med, Dept Internal Med, Nakhon Nayok, Thailand

[11] Chiang Mai Univ, Mueang Chiang Mai, Thailand

[12] Phramongkutklao Coll Med, Bangkok, Thailand

[13] Udon Thani Hosp, Udon Thani, Thailand

[14] Queen Savang Vadhana Mem Hosp, Si Racha, Thailand

[15] Minist Publ Hlth, Sakon Nakhon Hosp, Bangkok, Thailand

[16] Mahidol Univ, Fac Med, Dept Med, Div Med Oncol,Siriraj Hosp, Bangkok, Thailand

[17] Ramathibodi Hosp, Dept Med, Fac Med, Ratchathewi, Thailand

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期

关键词：

D O I：

10.1200/JCO.2025.43.4_suppl.607

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：607 / 607

页数：1

共 50 条

[1] Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study
Rimini, Margherita
Masi, Gianluca
Lonardi, Sara
Pressiani, Tiziana
Lavacchi, Daniele
Nichetti, Federico
Jessica, Lucchetti
Giordano, Guido
Scartozzi, Mario
Tamburini, Emiliano
Pastorino, Alessandro
Rapposelli, Ilario Giovanni
Daniele, Bruno
Martinelli, Erika
Garajova, Ingrid
Aprile, Giuseppe
Schirripa, Marta
Formica, Vincenzo
Salani, Francesca
Winchler, Costanza
Bergamo, Francesca
Balsano, Rita
Gusmaroli, Eleonora
Lorenzo, Angotti
Landriscina, Matteo
Pretta, Andrea
Toma, Ilaria
Pirrone, Chiara
Diana, Anna
Leone, Francesco
Brunetti, Oronzo
Brandi, Giovanni
Garattini, Silvio Ken
Satolli, Maria Antonietta
Rossari, Federico
Fornaro, Lorenzo
Niger, Monica
Zanuso, Valentina
De Rosa, Antonio
Ratti, Francesca
Aldrighetti, Luca
De Braud, Filippo
Foti, Silvia
Rizzato, Mario Domenico
Vivaldi, Caterina
Stefano, Cascinu
Rimassa, Lorenza
Antonuzzo, Lorenzo
Casadei-Gardini, Andrea
TARGETED ONCOLOGY, 2024, 19 (3) : 359 - 370
[2] Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data
Alexander Olkus
Aurelie Tomczak
Anne Katrin Berger
Conrad Rauber
Philip Puchas
Cyrill Wehling
Thomas Longerich
Arianeb Mehrabi
De-Hua Chang
Jakob Liermann
Sophia Schäfer
Jan Pfeiffenberger
Dirk Jäger
Patrick Michl
Christoph Springfeld
Michael T. Dill
Targeted Oncology, 2024, 19 : 213 - 221
[3] Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data
Olkus, Alexander
Tomczak, Aurelie
Berger, Anne Katrin
Rauber, Conrad
Puchas, Philip
Wehling, Cyrill
Longerich, Thomas
Mehrabi, Arianeb
Chang, De-Hua
Liermann, Jakob
Schaefer, Sophia
Pfeiffenberger, Jan
Jaeger, Dirk
Michl, Patrick
Springfeld, Christoph
Dill, Michael T.
TARGETED ONCOLOGY, 2024, 19 (02) : 213 - 221
[4] Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data
Rimini, M.
Fornaro, L.
Lonardi, S.
Niger, M.
Lucchetti, J.
Giordano, G.
Scartozzi, M.
Tamburini, E.
Rapposelli, I.
Martinelli, E.
Garajova, I.
Schirripa, M.
Rimassa, L.
Antonuzzo, L.
Gardini, A. Casadei
ANNALS OF ONCOLOGY, 2023, 34 : S28 - S28
[5] Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data
Rimini, Margherita
Fornaro, Lorenzo
Lonardi, Sara
Niger, Monica
Lavacchi, Daniele
Pressiani, Tiziana
Lucchetti, Jessica
Giordano, Guido
Pretta, Andrea
Tamburini, Emiliano
Pirrone, Chiara
Rapposelli, Ilario Giovanni
Diana, Anna
Martinelli, Erika
Garajova, Ingrid
Simionato, Francesca
Schirripa, Marta
Formica, Vincenzo
Vivaldi, Caterina
Caliman, Enrico
Rizzato, Mario Domenico
Zanuso, Valentina
Nichetti, Federico
Angotti, Lorenzo
Landriscina, Matteo
Scartozzi, Mario
Ramundo, Matteo
Pastorino, Alessandro
Daniele, Bruno
Cornara, Noemi
Persano, Mara
Gusmaroli, Eleonora
Cerantola, Riccardo
Salani, Francesca
Ratti, Francesca
Aldrighetti, Luca
Cascinu, Stefano
Rimassa, Lorenza
Antonuzzo, Lorenzo
Casadei-Gardini, Andrea
LIVER INTERNATIONAL, 2023, 43 (08) : 1803 - 1812
[6] The survival impact of the addition of durvalumab to cisplatin/gemcitabine in advanced biliary tract cancer: A real-world, retrospective, multicentric study
Rimini, M.
Persano, M.
Foti, S.
Fornaro, L.
Lonardi, S.
Niger, M.
Tamburini, E.
Lavacchi, D.
Rapposelli, I. G.
Martinelli, E.
Garajova, I.
Simionato, F.
Camera, S.
Rossari, F.
Amadeo, E.
Vitiello, F.
Cascinu, S.
Rimassa, L.
Antonuzzo, L.
Gardini, A. Casadei
ANNALS OF ONCOLOGY, 2023, 34 : S1528 - S1528
[7] Gemcitabine Cisplatin and Durvalumab Experience in Advanced Biliary Tract Cancers: A Real-World, Multicentric Data From India
Muddu, Vamshi Krishna
Shah, Anjali
John, Anupa
Raj, Abhishek
Bahl, Ankur
Rajappa, Senthil J.
Raja, Thirumalairaj
Ghosh, Joydeep
Lavingia, Viraj
Vora, Amish
Bhargava, Prabhat
Ramaswamy, Anant
Khan, Arif
Sharma, Atul
Trikha, Mehak
Dhanawat, Aditya
Bonda, Avinash
Siripurapu, Indraja
Mahajan, Manoj
Rohatgi, Nitesh
Chandrakant, Mosale Venkatesha
Gujarathi, Himanshu
Vora, Manan
Ankathi, Sumankumar
Ostwal, Vikas S.
JCO GLOBAL ONCOLOGY, 2024, 10
[8] TREATMENT WITH GEMCITABINE/CISPLATIN AND DURVALUMAB FOR BILIARY TRACT CANCER - FIRST REAL-WORLD DATA FROM A GERMAN PATIENT COHORT
Gerhardt, Florian
Mueller, Christian
Chater, Jack
Schindler, Aaron
Ebel, Sebastian
Venerito, Marino
Berg, Thomas
Van Boemmel, Florian
HEPATOLOGY, 2023, 78 : S1905 - S1905
[9] Durvalumab Plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer (TOPAZ-1)
Choe, Jung Wan
KOREAN JOURNAL OF GASTROENTEROLOGY, 2023, 82 (02): : 105 - 106
[10] Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population
Rimini, Margherita
Fornaro, Lorenzo
Rizzato, Mario Domenico
Antonuzzo, Lorenzo
Rossari, Federico
Satake, Tomoyuki
Vandeputte, Hanne
Vivaldi, Caterina
Pressiani, Tiziana
Lucchetti, Jessica
Kim, Jin Won
Abidoye, Oluseyi
Rapposelli, Ilario Giovanni
Tamberi, Stefano
Finkelmeier, Fabian
Giordano, Guido
Nichetti, Federico
Chon, Hong Jae
Braconi, Chiara
Pirrone, Chiara
Castet, Florian
Tamburini, Emiliano
Yoo, Changhoon
Parisi, Alessandro
Diana, Anna
Scartozzi, Mario
Prager, Gerald W.
Avallone, Antonio
Schirripa, Marta
Kim, Il Hwan
Perkhofer, Lukas
Oneda, Ester
Verrico, Monica
Adeva, Jorge
Chan, Stephen L.
Spinelli, Gian Paolo
Personeni, Nicola
Garajova, Ingrid
Rodriquenz, Maria Grazia
Leo, Silvana
Salani, Francesca
De Rosa, Antonio
Lavacchi, Daniele
Foti, Silvia
Ikeda, Masafumi
Dekervel, Jeroen
Niger, Monica
Balsano, Rita
Tonini, Giuseppe
Kang, Minsu
EUROPEAN JOURNAL OF CANCER, 2024, 208

← 1 2 3 4 5 →